Dr. Carol Chow
Founder & CEO, Sylvanus Asia Pte Ltd and Opulentia Capital Pte Ltd
PhD, Accounting & Finance — National University of Singapore
Carol Chow has spent over fifteen years in capital operations on both sides of the China–West divide, almost always as the person accountable rather than the person advising. She has been chief executive of a Shanghai-listed developer, managing director of a Singapore-listed pharmaceutical group, vice president of business strategy at a Hong Kong-listed resources company, and vice president of sales at a mainland securities house.
At Lang Fang City Development (SHEX: 600149) she raised RMB 2 billion, built the institutional partnerships behind it, and steered the company through the 2015 Chinese market crash with shareholder interests intact and the stock recovered. At ATL Group she led the NYSE listing programme, managing US and Chinese stakeholders simultaneously — a corridor very few practitioners have actually run end to end.
In Singapore she founded and launched a multi-strategy capital VCC for Atlantis Investment Management in under three months, rebuilt the office single-handedly, hired the local team from nothing and secured a new sovereign fund relationship. She subsequently founded Sylvanus Asia and Opulentia Capital, her own sustainability investment and ESG advisory platforms, which she leads today. In London she founded and ran ACE Academy. Earlier, she taught financial accounting to postgraduates and MBAs at the University of Queensland in Brisbane.
Chow & Partners is the vehicle through which she now takes a small number of private mandates. The practice exists because the situations she is asked about — a family structure that has outgrown its bank, a deal that will not close on economics alone, a fund that needs Asia to be real — are not problems an institution solves. They are problems a person solves.
Founder & CEO — Sylvanus Asia Pte Ltd / Opulentia Capital Pte Ltd, Singapore
Sustainability investment and ESG advisory. Origination and structuring of impact projects, fund management and return discipline for investors.
Chief Executive Officer — Atlantis Investment Management, Singapore
Founded and launched a multi-strategy capital VCC in under three months. Rebuilt the Singapore office single-handedly, built the local team from the ground up, secured a new sovereign fund relationship, owned the regulatory perimeter.
Founder & Managing Director — ACE Academy, London
Founded and scaled a UK operating business: strategy, fundraising, legal compliance, client relationships and team.
Chief Executive Officer — ATL Group, Xiamen, China
Led the NYSE listing initiative across US and Chinese stakeholders. Capital operations, fundraising, M&A, corporate governance and investor relations.
Vice President, Sales — China Industrial Securities (Shanghai) Ltd
Fixed income and debt instruments across retail banks, pension funds and private equity clients, with full regulatory compliance ownership.
Chief Executive Officer — Lang Fang City Development (SHEX: 600149)
Raised RMB 2 billion. Built partnerships with leading financial institutions. Navigated the 2015 market crash and delivered a stock recovery with shareholder interests protected.
Managing Director — Star Pharmaceutical Ltd (SGX: STARPHARM), Singapore
Business strategy and board counsel, capital markets operations, risk management, pharmaceutical acquisitions and a complex privatisation process.
VP, Business Strategy — China Asean Resources Ltd (HKEX: 08186), Hong Kong
Long-range planning, financial oversight, governance alignment, budgeting and forecasting behind the group investment strategy.
Assistant Professor, Finance & Accounting — University of Queensland, Brisbane
Postgraduate and MBA teaching in financial accounting.
PhD, Accounting & Finance — National University of Singapore
Doctoral research in accounting and finance. Also holds the Certificate in ESG Investing.
Six capabilities that are difficult to hire.
Operator, not adviser
Almost every credential is a CEO or MD seat, not a consulting engagement. She has signed the decisions, not the recommendations.
Four exchanges, personally
NYSE, HKEX, SGX and SHEX. Advisers who have worked on all four as an operator are close to non-existent.
The China–West corridor, both directions
Mainland securities and listed-company leadership on one side; London, Brisbane and US stakeholder management on the other. Native in both registers.
Crisis-tested
Led a Shanghai-listed company through the 2015 crash and protected shareholders. Judgement under real downside, not modelled downside.
Sovereign and institutional access
A new sovereign fund relationship secured from a standing start, plus institutional partnerships behind an RMB 2bn raise.
Academic rigour underneath
A PhD in accounting and finance and a university teaching record — the technical floor beneath the deal instinct.
Enquiries are read by the principal.
We reply to every serious approach, and decline most of them. If the situation is time-critical, say so in the first line.
Request an introduction